Therefore, these results indicated that avitinib significantly attenuates bleomycin-induced pulmonary fibrosis mainly by suppressing TGF-β1/Smad signalling in vivo, but further in vitro mechanistic studies are needed. Here, TGFB1 is linked to pulmonary fibrosis.